Cara Therapeutics Inc
(NAS:CARA)
$
0.378
-0.0719 (-15.98%)
Market Cap: 20.73 Mil
Enterprise Value: -13.94 Mil
PE Ratio: 0
PB Ratio: 37.80
GF Score: 35/100 Cara Therapeutics Inc at Needham Healthcare Conference (Virtual) Transcript
Apr 17, 2023 / 05:30PM GMT
Release Date Price:
$4.43
(+4.73%)
Joey Stringer
Needham & Company, LLC - Analyst
Good afternoon, everyone. Thank you for joining the 22nd Annual Needham Healthcare Conference. My name is Joey Stringer, and I'm one of the biotech analysts at Needham & Company. It's my pleasure to introduce our next presenting company, Cara Therapeutics. Joining us today from Cara is President and CEO, Chris Posner; CFO, Ryan Maynard; and CMO, Joana Goncalves.
For those of you joining us on the webcast, if you want to ask a question, please do so at any time. You can submit a question using the chat box at the bottom of your screen.
So with that, we'll get started. Members of the Cara team, thank you so much for joining us today.
Chris Posner
Cara Therapeutics, Inc. - CEO, President, & Director
Good afternoon, Joey.
Ryan Maynard
Cara Therapeutics, Inc. - CFO
Thanks for having us, Joe.
Joana Goncalves
Cara Therapeutics, Inc. - Chief Medical Officer
Thank you.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot